BRI Ventures was part of a consortium that provided $53m for mobile wallet developer Payfazz, which also counts Telkom Indonesia as an investor.

The mother-focused recruitment platform developer increased its total funding to about $36m in a round that included new investors Citi and Synchrony.

Existing backer GV helped the data storage technology provider hike its overall funding to more than $56m as it appoints a new chief executive.

The genetic testing services provider has added a Samsung-led second close to a $23m first tranche that included a range of corporate investors.

Equinor Ventures participated in a series B that represents the CO2 separation technology provider's second funding round this year.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

University of Zurich-founded skin graft therapy developer Cutiss increased its funding total to $29.3m with a round featuring Wyss Foundation.

Sunshine Insurance intends to set up a $142m industrial investment fund with student services provider AW having led its $28.3m series B funding.

Advancing research from institutions including Harvard, kidney disease-focused Goldfinch Bio now has its sights on clinical trials.

Existing backer Gilead Sciences returned for a series B round that boosted the kidney disease therapy developer's total funding to $160m.